Varied opinions on thrombolysis for venous thromboembolism in infants and children: Findings from a survey of pediatric hematology-oncology specialists

Pediatric Blood and Cancer

Volumn 53, Issue 6, 2009, Pages 960-966

  Yee, Donald L ^a   Chan, Anthony K C ^b   Williams, Suzan ^c   Goldenberg, Neil A ^d,e   Massicotte, M Patricia ^f   Raffini, Leslie J ^g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d University of Colorado Denver and Children s Hospital Colorado   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Pediatric; Thrombolysis; Thrombolytic; Thrombosis; tPA

Indexed keywords

FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; HEPARIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ADJUVANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; CATHETERIZATION; CONSENSUS DEVELOPMENT; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG PREFERENCE; E-MAIL; HEALTH SURVEY; INTENSIVE CARE; LOW DRUG DOSE; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLIC OPINION; QUESTIONNAIRE; SURGICAL THROMBECTOMY; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FIBRINOLYTIC AGENTS; HUMANS; INFANT; INFANT, NEWBORN; PHYSICIANS; THROMBOLYTIC THERAPY; VENOUS THROMBOEMBOLISM;

EID: 71049179956     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22146     Document Type: Article

References (22)

1. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:887S-968S. (Pubitemid 351892979)
2. Goldenberg NA, Durham JD, Knapp-Clevenger R, et al. A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood 2007;110:45-53. (Pubitemid 47026817)
3. Albisetti M. Thrombolytic therapy in children. Thromb Res 2006;118:95-105.
4. Wang M, Hays T, Balasa V, et al. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol 2003; 25:379-386. (Pubitemid 36569969)
5. Manco-Johnson MJ, Grabowski EF, Hellgreen M, et al. Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 2002; 88:157-158.
6. Manco-Johnson MJ, Nuss R, Hays T, et al. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr 2000;136:446-453. (Pubitemid 30469584)
7. Gupta AA, Leaker M, Andrew M, et al. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 2001;139:682-688. (Pubitemid 33097434)
8. Manco-Johnson MJ. How I treat venous thrombosis in children. Blood 2006;107:21-29. (Pubitemid 43053518)
9. Vesely SK, Buchanan GR, Adix L, et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: Results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003;25:130-133. (Pubitemid 36194040)
10. Vesely S,BuchananGR,Cohen A, et al. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: Results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol 2000; 22:55-61.
11. Wong EC, Perez-Albuerne E, Moscow JA, et al. Transfusion management strategies: A survey of practicing pediatric hematology/ oncology specialists. Pediatr Blood Cancer 2005;44:119-127. (Pubitemid 40041527)
12. Skinner R, Koller K, McIntosh N, et al. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer. Pediatr Blood Cancer 2008;50:826-830. (Pubitemid 351354793)
13. Sharathkumar AA. Current practice perspectives on the management of thrombosis in children with renal insufficiency: The results of a survey of pediatric hematologists in North America. Pediatr Blood Cancer 2008;51:657-661.
14. Neunert CE, Bright BC, Buchanan GR. Severe chronic refractory immune thrombocytopenic purpura during childhood: A survey of physician management. Pediatr Blood Cancer 2008;51:513-516.
15. Newall F, Browne M, Savoia H, et al. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics. J Pediatr Hematol Oncol 2007;29:269-273. (Pubitemid 46597694)
16. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:454S-545S. (Pubitemid 351892971)
17. Segal JB, Streiff MB, Hofmann LV, et al. Management of venous thromboembolism: A systematic review for a practice guideline. Ann Intern Med 2007;146:211-222. (Pubitemid 351650635)
18. Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2004; CD002783.
19. tPA drug label. http://www.fda.gov/CDER/biologics/products/ altegen051502.htm. Accessed 05/10/2009.
20. Raffini L. Thrombolysis for intravascular thrombosis in neonates and children. Curr Opin Pediatr 2009;21:9-14.
21. Hartmann J, Hussein A, Trowitzsch E, et al. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: Six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed 2001;85:F18-F22. (Pubitemid 32634819)
22. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 2004;351: 1081-1088. (Pubitemid 39167512)